CHICAGO (GenomeWeb) – Vanderbilt University Medical Center in Nashville, Tennessee, is putting its genomics and bioinformatics expertise behind a newly unveiled commercial entity offering services and technology to the pharmaceutical and diagnostics industries.
Called Nashville Biosciences, the wholly owned subsidiary of Vanderbilt will lean heavily on BioVU, Vanderbilt's bank of longitudinal medical records and DNA samples that now contains more than 250,000 specimens.